Can a targeted drug curb the devastating attacks of NMOSD?
Disease control
Recruiting now
This study looks at whether giving satralizumab early during an attack of neuromyelitis optica spectrum disorder (NMOSD) can improve recovery and reduce long-term disability. Researchers will follow 50 adults with NMOSD who receive satralizumab as part of their routine care, trac…
Sponsor: Junwei Hao, MD • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC